Slow Interstitial Fluid Flow Activates TGF-β Signaling and Drives Fibrotic Responses in Human Tenon Fibroblasts

Cells. 2023 Sep 4;12(17):2205. doi: 10.3390/cells12172205.

Abstract

Background: Fibrosis limits the success of filtering glaucoma surgery. We employed 2D and 3D in vitro models to assess the effects of fluid flow on human tenon fibroblasts (HTF).

Methods: HTF were exposed to continuous or pulsatile fluid flow for 48 or 72 h, at rates expected at the transscleral outflow site after filtering surgery. In the 2D model, the F-actin cytoskeleton and fibronectin 1 (FN1) were visualized by confocal immunofluorescence microscopy. In the 3D model, mRNA and whole cell lysates were extracted to analyze the expression of fibrosis-associated genes by qPCR and Western blot. The effects of a small-molecule inhibitor of the TGF-β receptor ALK5 were studied.

Results: Slow, continuous fluid flow induced fibrotic responses in the 2D and 3D models. It elicited changes in cell shape, the F-actin cytoskeleton, the deposition of FN1 and activated the intracellular TGF-β signaling pathway to induce expression of fibrosis-related genes, such as CTGF, FN1 and COL1A1. ALK5-inhibition reduced this effect. Intermittent fluid flow also induced fibrotic changes, which decreased with increasing pause duration.

Conclusions: Slow interstitial fluid flow is sufficient to induce fibrosis, could underlie the intractable nature of fibrosis following filtering glaucoma surgery and might be a target for antifibrotic therapy.

Keywords: ALK5 inhibitor; collagen; extracellular matrix; fibronectin; fibrosis; glaucoma surgery; myofibroblast; scarring.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Actin Cytoskeleton
  • Actins
  • Cytoskeleton
  • Extracellular Fluid*
  • Glaucoma*
  • Humans

Substances

  • Actins

Grants and funding

This study was supported by Freunde der Universitäts-Augenklinik Freiburg e.V. by providing a research fellowship (to K.Z.) and material support (syringe pump, funding number 1027085301); and Deutsche Ophthalmologische Gesellschaft by providing a research fellowship (to J.F.); and a startup grant by Forschungskommission der Medizinischen Fakultät der Albert-Ludwigs-Universität Freiburg (Funding number: LUE2123/19, to C.J.W.). We acknowledge support by the Open Access Publication Fund of the University of Freiburg.